Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Chemotherapies
Advanced stage mucinous epithelial ovarian cancer studied
July 14th, 2005
Advanced stage mucinous epithelial ovarian cancer (mEOC) was reported. According to recent research from Greece, "mEOC, representing about 10% of all EOC, are known to be possibly resistant to platinum-based chemotherapy and bear a poorer prognosis with respect to other subtypes of EOC." "This study was undertaken to compare response and survival to platinum-based chemotherapy between patients with advanced stages III and IV mEOC and serous EOC (sEOC). A retrospective analysis was performed in 47 patients with advanced stage of mEOC treated with first-line platinum-based chemotherapy in the context of several study protocols of the Hellenic...
Source: Women's Health Weekly (2005-07-14)
|
